Cigna (CI)CEO bought ~$1M

~$1M

Approx. value · 4,134 sh @ $241.88

158K

Holds after · shares reported

Traded

Nov 3, 2025

Filed

Nov 3, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 23, 2024CongressDisclosed purchase of CI — reported range $1,001 - $15,000
2. Oct 29, 2024Congress · 1 personMembers of Congress: 2 purchases
3. Apr 22, 2025Congress · 1 personMembers of Congress: 2 sales
4. Aug 5, 2025Congress · 1 personMembers of Congress: 2 sales
5. Aug 14, 2025CongressDisclosed partial sale of CI — reported range $1,001 - $15,000
6. Sep 23, 2025CongressDisclosed sale of CI — reported range $1,001 - $15,000
7. Sep 25, 2025CongressDisclosed sale of CI — reported range $1,001 - $15,000
8. Oct 3, 2025InsiderOfficer sold ~$1.61M of CI shares in the open market
9. Oct 15, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 15, 2025, Retired Major General Elder Granger, M.D. informed the Board of Directors (the “Board”) of The Cigna Group (the “Company”) that he will retire from the Board effective December 31, 2025.”
10. Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
11. Nov 3, 2025 · this disclosureInsider · First insider buy since Aug 2021CEO purchased ~$1000K of CI shares in the open market

What came next

1. Nov 5, 20255% stakeFMR LLC reported a passive stake (13G) of 4.0%
2. Nov 12, 2025CongressDisclosed sale of CI — reported range $1,001 - $15,000
3. Nov 13, 2025CongressDisclosed partial sale of CI — reported range $1,001 - $15,000
4. Dec 18, 2025Congress · 1 personMembers of Congress: 2 sales
5. Dec 19, 2025CongressDisclosed purchase of CI — reported range $1,001 - $15,000
6. Feb 5, 2026Company filing · Form 8-K · ResultsReported its results
7. Feb 12, 2026Government · Federal Register noticeExpress Scripts, Inc., et al.; Analysis of Agreement Containing Consent Order To Aid Public Comment
8. Feb 25, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On February 25, 2026, the Board of Directors (the “Board”) of The Cigna Group (the “Company”) appointed Mr. Brian C. Evanko as Chief Executive Officer (“CEO”) of the Company, effective July 1, 2026.”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cigna

For Cigna, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 27 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CI page.

Other recent filings by David Cordani, Chairman & CEO

• SEC Form 4 at Cigna (CI)May 14, 2026
• SEC Form 4 at Cigna (CI)May 14, 2026
• SEC Form 4 at Cigna (CI)May 14, 2026
• SEC Form 4 at Cigna (CI)May 14, 2026
• SEC Form 4 at Cigna (CI)May 14, 2026

The full history of David Cordani, Chairman & CEO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Cigna

• SEC Form 4Sep 8, 2026
• SEC Form 144Sep 3, 2026
• SEC Form 4Aug 20, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its CI page.